-
1
-
-
67649984773
-
Blood manufacturing: Component preparation, storage, and transportation
-
In. Hillyer, C.D. Silberstein, L.E. Ness, P.M. Anderson, K.C. Roback, J.D. editors. ed. Philadelphia (PA). Churchill Livingstone. p.
-
Harris SB, Hillyer CD. Blood manufacturing: component preparation, storage, and transportation. In : Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roback JD, editors. Blood banking and transfusion medicine. 2nd ed. Philadelphia (PA) : Churchill Livingstone 2007. p. 183 204.
-
(2007)
Blood Banking and Transfusion Medicine. 2nd
, pp. 183-204
-
-
Harris, S.B.1
Hillyer, C.D.2
-
2
-
-
26244462802
-
Bacterial detection of platelets: Current problems and possible resolutions
-
Blajchman MA, Beckers EA, Dickmeiss E, Lin L, Moore G, Muylle L. Bacterial detection of platelets: current problems and possible resolutions. Transfus Med Rev 2005 19 : 259 72.
-
(2005)
Transfus Med Rev
, vol.19
, pp. 259-72
-
-
Blajchman, M.A.1
Beckers, E.A.2
Dickmeiss, E.3
Lin, L.4
Moore, G.5
Muylle, L.6
-
3
-
-
0031452585
-
The threshold for prophylactic platelet transfusions in adults with acute myelogenous leukemia
-
Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, Barbui T, Mandelli F, Sirchia G. The threshold for prophylactic platelet transfusions in adults with acute myelogenous leukemia. N Engl J Med 1997 337 : 1870 5.
-
(1997)
N Engl J Med
, vol.337
, pp. 1870-5
-
-
Rebulla, P.1
Finazzi, G.2
Marangoni, F.3
Avvisati, G.4
Gugliotta, L.5
Tognoni, G.6
Barbui, T.7
Mandelli, F.8
Sirchia, G.9
-
4
-
-
2642611953
-
Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions
-
TRAP Study Group.
-
TRAP Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997 337 : 1861 9.
-
(1997)
N Engl J Med
, vol.337
, pp. 1861-9
-
-
-
5
-
-
0042845841
-
Prophylactic platelet transfusions: Which dose is the best dose? A review of the literature
-
Tinmouth AT, Freedman J. Prophylactic platelet transfusions: which dose is the best dose? A review of the literature. Transfus Med Rev 2003 17 : 181 93.
-
(2003)
Transfus Med Rev
, vol.17
, pp. 181-93
-
-
Tinmouth, A.T.1
Freedman, J.2
-
6
-
-
33745153101
-
Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients
-
Slichter SJ. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients. J Clin Apher 2006 21 : 78 84.
-
(2006)
J Clin Apher
, vol.21
, pp. 78-84
-
-
Slichter, S.J.1
-
7
-
-
42949159998
-
Evidence-based platelet transfusion guidelines
-
In. Gewirtz, A.M. Winter, J.N. Zuckerman, K. editors. Washington, DC. American Society of Hematology. p.
-
Slichter SJ. Evidence-based platelet transfusion guidelines. In : Gewirtz AM, Winter JN, Zuckerman K, editors. American Society of Hematology education program book. Washington, DC : American Society of Hematology 2007. p. 172 8.
-
(2007)
American Society of Hematology Education Program Book.
, pp. 172-8
-
-
Slichter, S.J.1
-
8
-
-
67649997191
-
Impact of photochemical treatment (INTERCEPT™) on platelet use in routine practice
-
Suppl
-
Osselaer J, Doyen C, Chatelain C, Debry C, Goffaux M, Messe N, Van Hooydonk M, Sonnet A, Bosly A, Lin JS, Corash L. Impact of photochemical treatment (INTERCEPT™) on platelet use in routine practice. Vox Sang 2006 91 Suppl 3 : 180.
-
(2006)
Vox Sang
, vol.91
, Issue.3
, pp. 180
-
-
Osselaer, J.1
Doyen, C.2
Chatelain, C.3
Debry, C.4
Goffaux, M.5
Messe, N.6
Van Hooydonk, M.7
Sonnet, A.8
Bosly, A.9
Lin, J.S.10
Corash, L.11
-
9
-
-
36649022874
-
Proceedings of a consensus conference: Pathogen inactivation-making decisions about new technologies. Clinical experience with pathogen-inactivated platelets
-
Cazenave JP. Proceedings of a consensus conference: pathogen inactivation-making decisions about new technologies. Clinical experience with pathogen-inactivated platelets. Transfusion Med Reviews 2008 22 : 1 34.
-
(2008)
Transfusion Med Reviews
, vol.22
, pp. 1-34
-
-
Cazenave, J.P.1
-
10
-
-
36348962917
-
Pathogen inactivation: Making decisions about new technologies: Report of a consensus conference
-
Klein HG, Anderson D, Bernardi MJ, Cable R, Carey W, Hoch JS, Robitaille N, Sivilotti ML, Smaill F. Pathogen inactivation: making decisions about new technologies: report of a consensus conference. Transfusion 2007 47 : 2338 47.
-
(2007)
Transfusion
, vol.47
, pp. 2338-47
-
-
Klein, H.G.1
Anderson, D.2
Bernardi, M.J.3
Cable, R.4
Carey, W.5
Hoch, J.S.6
Robitaille, N.7
Sivilotti, M.L.8
Smaill, F.9
-
11
-
-
0037443546
-
Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: The euroSPRITE trial
-
van Rhenen D J, Gulliksson H, Cazenave JP, Pamphilon D, Ljungman P, Klüter H, Vermeij H, Kappers-Klunne M, de Greef G, Laforet M, Lioure B, Davis K, Marblie S, Mayaudon V, Flament J, Conlan M, Lin L, Metzel P, Buchholz D, Corash L euroSPRITE trial. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003 101 : 2426 33.
-
(2003)
Blood
, vol.101
, pp. 2426-33
-
-
Van Rhenen, D.J.1
Gulliksson, H.2
Cazenave, J.P.3
Pamphilon, D.4
Ljungman, P.5
Klüter, H.6
Vermeij, H.7
Kappers-Klunne, M.8
De Greef, G.9
Laforet, M.10
Lioure, B.11
Davis, K.12
Marblie, S.13
Mayaudon, V.14
Flament, J.15
Conlan, M.16
Lin, L.17
Metzel, P.18
Buchholz, D.19
-
12
-
-
4444380592
-
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: The SPRINT trial
-
McCullough J, Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, Goodnough LT, Fridey JL, Raife T, Cable R, Murphy S, Howard F 4th., Davis K, Lin JS, Metzel P, Corash L, Koutsoukos A, Lin L, Buchholz DH, Conlan MG. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT trial. Blood 2004 104 : 1534 41.
-
(2004)
Blood
, vol.104
, pp. 1534-41
-
-
McCullough, J.1
Vesole, D.H.2
Benjamin, R.J.3
Slichter, S.J.4
Pineda, A.5
Snyder, E.6
Stadtmauer, E.A.7
Lopez-Plaza, I.8
Coutre, S.9
Strauss, R.G.10
Goodnough, L.T.11
Fridey, J.L.12
Raife, T.13
Cable, R.14
Murphy, S.15
Howard IV, F.16
Davis, K.17
Lin, J.S.18
Metzel, P.19
Corash, L.20
Koutsoukos, A.21
Lin, L.22
Buchholz, D.H.23
Conlan, M.G.24
more..
-
13
-
-
26944442457
-
Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set
-
Janetzko K, Cazenave JP, Kluter H, Kientz D, Michel M, Beris P, Lioure B, Hastka J, Marblie S, Mayaudon V, Lin L, Lin JS, Conlan MG, Flament J. Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set. Transfusion 2005 45 : 1443 52.
-
(2005)
Transfusion
, vol.45
, pp. 1443-52
-
-
Janetzko, K.1
Cazenave, J.P.2
Kluter, H.3
Kientz, D.4
Michel, M.5
Beris, P.6
Lioure, B.7
Hastka, J.8
Marblie, S.9
Mayaudon, V.10
Lin, L.11
Lin, J.S.12
Conlan, M.G.13
Flament, J.14
-
15
-
-
10444279184
-
111 indium radiolabeled platelets treated with pathogen inactivation using amotosalen HCl (S-59) and UVA light
-
111 indium radiolabeled platelets treated with pathogen inactivation using amotosalen HCl (S-59) and UVA light. Transfusion 2004 44 : 1732 440.
-
(2004)
Transfusion
, vol.44
, pp. 1732-440
-
-
Snyder, E.1
Raife, T.2
Lin, L.3
Cimino, G.4
Metzel, P.5
Rheinschmidt, M.6
Baril, L.7
Davis, K.8
Buchholz, D.H.9
Corash, L.10
Conlan, M.G.11
-
16
-
-
33644841313
-
Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: An analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light
-
DOI 10.1111/j.1537-2995.2005.00671.x
-
Murphy S, Snyder E, Cable R, Slichter SJ, Strauss RG, McCullough J, Lin JS, Corash L, Conlan MG SPRINT Study Group. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light. Transfusion 2006 46 : 24 33. (Pubitemid 43381781)
-
(2006)
Transfusion
, vol.46
, Issue.1
, pp. 24-33
-
-
Murphy, S.1
Snyder, E.2
Cable, R.3
Slichter, S.J.4
Strauss, R.G.5
McCullough, J.6
Lin, J.-S.7
Corash, L.8
Conlan, M.G.9
-
17
-
-
42149179954
-
An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment
-
Osselaer JC, Cazenave JP, Lambermont M, Garraud O, Hidajat M, Barbolla L, Tardivel R, Defoin L, Waller C, Mendel I, Raidot JP, Kandel G, De Meuter R, Fabrigli P, Dehenau D, Arroyo JL, Padrón F, Gouezec H, Corral M, Jacquet M, Sundin D, Lin L, Corash L. An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment. Vox Sang 2008 94 : 315 23.
-
(2008)
Vox Sang
, vol.94
, pp. 315-23
-
-
Osselaer, J.C.1
Cazenave, J.P.2
Lambermont, M.3
Garraud, O.4
Hidajat, M.5
Barbolla, L.6
Tardivel, R.7
Defoin, L.8
Waller, C.9
Mendel, I.10
Raidot, J.P.11
Kandel, G.12
De Meuter, R.13
Fabrigli, P.14
Dehenau, D.15
Arroyo, J.L.16
Padrón, F.17
Gouezec, H.18
Corral, M.19
Jacquet, M.20
Sundin, D.21
Lin, L.22
Corash, L.23
more..
-
18
-
-
44849088730
-
A prospective observational cohort safety study of 5106 platelet transfusions using components prepared with photochemical pathogen inactivation treatment
-
Osselaer JC, Messe N, Hervig T, Bueno J, Castro E, Espinosa A, Accorsi P, Junge K, Jacquet M, Flament J, Corash L. A prospective observational cohort safety study of 5106 platelet transfusions using components prepared with photochemical pathogen inactivation treatment. Transfusion 2008 48 : 1061 71.
-
(2008)
Transfusion
, vol.48
, pp. 1061-71
-
-
Osselaer, J.C.1
Messe, N.2
Hervig, T.3
Bueno, J.4
Castro, E.5
Espinosa, A.6
Accorsi, P.7
Junge, K.8
Jacquet, M.9
Flament, J.10
Corash, L.11
|